title: [Decision of the Federal Joint Committee on screening for chorionicity - benefit assessment in the absence of screening studies].
abstract: The main decision-making body of the self-government system in Germany is the Federal Joint Committee (G-BA). In line with the principles of evidence-based medicine, randomised controlled trials with patient-relevant endpoints (in particular mortality, morbidity, quality of life) are preferred for the G-BA assessment of medical treatments and procedures. During this analysis of ultrasound screening for monochorionicity in multiple pregnancies, no studies were identified directly comparing a group with screening vs. a group without screening. Therefore, a 3-step process, which assesses the single components of screening (risk factors, relevant outcome for the patient, existence of a confirmed diagnosis, application of an effective therapy), was used. On the basis of these results the G-BA decided that the statutory health insurance should include the determination of chorionicity in their reimbursement catalogue.
authors: Abteilung Fachberatung Medizin, Gemeinsamer Bundesausschuss, Berlin.
authors: A
authors: A
authors: Schwalm
authors: H
authors: H
authors: Bertelsmann
authors: S
authors: S
authors: Gruber
authors: G
authors: G
authors: Wietschel
authors: K
authors: K
authors: Matthias
mesh_terms: D003362:Cost-Benefit Analysis; D003657:Decision Making; D019317:Evidence-Based Medicine / Q000191:economics*; D005260:Female; D005858:Germany / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics*; D008403:Mass Screening / Q000191:economics*; D011247:Pregnancy; D011272:Pregnancy, Multiple; D016216:Ultrasonography, Prenatal / Q000191:economics*